| |
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel
|
| |
| |
Download the PDF here
Download the PDF here
-------------------------------------------
New HHS ART Guidelines discuss & Provide Guidance: Immunologc Aging, Bone Screening, Frailty, Cognitive Evaluations, Polypharmacy, DDIs in Older PWH - (12/19/24)
HIVMA-IDSA Guidance on Screening for Frailty, Neurocognitive Decline, Bone
Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America - (11/05/24)
New HIV Guidelines IAS-USA Panel; Screenings for Aging, Weight
Here, updated recommendations for HIV treatment and clinical management as well as HIV prevention based on the latest data are provided, and challenges that need additional attention and dedicated resources are highlighted.
Conclusions
HIV therapy continues to improve, with well-tolerated and highly effective oral regimens as well as long-acting injectable treatment for people who prefer to not take, or who have difficulty adhering to, daily therapy. In addition, there are new approaches to maintaining health in people with HIV, weight gain, including expanded indications for statins to reduce cardiovascular events and a new biomedical strategy, doxyPEP, to decrease STIs. HIV prevention through daily oral PrEP or long-acting injectables are crucial tools for ending the HIV epidemic in the US and around the world. However, although the tools are available, efforts must be redoubled to reduce disparities and address inequities to realize the promise of ending the HIV epidemic.
|
|
| |
| |
|
|
|
